SCP
PFE icon

Sivia Capital Partners’s Pfizer PFE Stock Holding History

Sivia Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Buy
+82,650
New +$2.16M 0.24% 88
2026
Q1 		– Sell
-8,865
Closed -$221K – 587
2025
Q4 		$221K Sell
8,865
-707
-7% -$17.8K 0.04% 497
2025
Q3 		$244K Buy
9,572
+1,009
+12% +$24.9K 0.07% 392
2025
Q2 		$208K Sell
8,563
-6,061
-41% -$141K 0.07% 397
2025
Q1 		$371K Buy
14,624
+4,271
+41% +$112K 0.17% 119
2024
Q4 		$275K Sell
10,353
-1,882
-15% -$51K 0.14% 128
2024
Q3 		$354K Sell
12,235
-140
-1% -$4.08K 0.21% 100
2024
Q2 		$346K Buy
12,375
+2,220
+22% +$61.1K 0.23% 81
2024
Q1 		$282K Buy
10,155
+181
+2% +$5.02K 0.19% 122
2023
Q4 		$287K Buy
+9,974
New +$302K 0.22% 100

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sivia Capital Partners's PFE Position: Q2 2026 in Review

Sivia Capital Partners opened a new position in Pfizer (PFE) in Q2 2026: 82,650 shares worth $1.99M. The stake represents 0.24% of the portfolio and ranks #88 among its holdings. This is a return to the name: Sivia Capital Partners previously reported a position in PFE as recently as Q4 2025.

Sivia Capital Partners first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sivia Capital Partners held 82,650 shares of Pfizer worth $1.99M as of Q2 2026.
  • Pfizer was a new Sivia Capital Partners position in Q2 2026.
  • Pfizer made up 0.24% of Sivia Capital Partners's portfolio in Q2 2026, its #88 holding.
  • Sivia Capital Partners first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.